Skip to content

DexCom Inc

DXCM· NasdaqCore metricsCIK 1093557

Surgical & medical instruments & apparatus142 peers

Last sale
Nov 12, 2026 · +1.29%
Market cap
$30.35B
372.95M shares
Filings
1,079
$1.34B
Q3 2026+15.6% FY25 yoy
$275.10M
Q3 2026+45.1% FY25 yoy
$327.20M
Q3 2026+52.0% FY25 yoy
$906.20M
Q3 2026derived+70.8% FY25 yoy
$0.72
Q3 2026+47.2% FY25 yoy
$961.40M
Q3 2026+51.4% FY25 yoy
$30.35B
30.6×
5.9×
12.0×
3.62%
—

Twelve months to Sep 30, 2026 · derived

Price

$81.39+40.04%+$23.27past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$4.66BFY 2025
$4.66B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$4,662,000,000reported
FY 20242024-12-31$4,033,000,000reported
FY 20232023-12-31$3,622,300,000reported
FY 20222022-12-31$2,909,800,000reported
FY 20212021-12-31$2,448,500,000reported
FY 20202020-12-31$1,926,700,000reported
FY 20192019-12-31$1,476,000,000reported
FY 20182018-12-31$1,031,600,000reported
FY 20172017-12-31$718,500,000reported
FY 20162016-12-31$573,300,000reported
FY 20152015-12-31$402,000,000reported
FY 20142014-12-31$259,200,000reported

Capital returns

Dividends and buybacks · FY2016 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$500.00M$500.00M—384.86M sh−1.5%46.4%
FY2024—$750.00M$750.00M—390.77M sh+1.4%118.9%
FY2023—$688.70M$688.70M—385.52M sh−0.2%134.5%
FY2022—$557.70M$557.70M—386.41M sh+298.1%183.0%
FY2021—$0.00$0.00—97.07M sh+0.9%0.0%

Segments

Geography
Revenue by Geography, FY2018 to FY2025FY2018United States · FY2018 · $818.40MInternational · FY2018 · $213.20MFY2019United States · FY2019 · $1.16BInternational · FY2019 · $314.50MFY2020United States · FY2020 · $1.51BInternational · FY2020 · $417.20MFY2021United States · FY2021 · $1.85BInternational · FY2021 · $599.10MFY2022United States · FY2022 · $2.14BInternational · FY2022 · $767.80MFY2023United States · FY2023 · $2.63BInternational · FY2023 · $997.00MFY2024United States · FY2024 · $2.89BInternational · FY2024 · $1.14BFY2025United States · FY2025 · $3.33BInternational · FY2025 · $1.33B
LineFY2025ShareChange
United States$3.33B72%+15.4%
International$1.33B28%+16.1%
Total$4.66B

From the 10-K filed Feb 12, 2026DXCM

Surgical & medical instruments & apparatus

DexCom Inc is the 9th largest of the 143 covered companies the SEC files under this code, by revenue. SIC 3841

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

DexCom Inc · CIK 1093557 · Engraved from SEC EDGAR